Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Journal of Geriatric Oncology
|
September 30, 2023
Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study
Gudrun Piringer, Josef Thaler, Sandro Anchisi, et al.
Anticancer Research
|
November 2, 2010
Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study)
Wu Zhang, Mizutomo Azuma, Georg Lurje, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2011
Common cancer stem cell gene variants predict colon cancer recurrence
Armin Gerger, Wu Zhang, Dongyun Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2012
Influence of sex on the survival of patients with esophageal cancer
Pierre Bohanes, Dongyun Yang, Ruchika S Chhibar, et al.
Cancers
|
July 27, 2022
Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study
Ralf-Dieter Hofheinz, Sandro Anchisi, Birgit Grünberger, et al.
BMC Cancer
|
February 20, 2021
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)
Karin Ribi, Beat Thürlimann, Corinne Schär, et al.
Journal of Bone Oncology
|
January 24, 2020
Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)
Michael Mark, Beat Thürlimann, Karin Ribi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 28, 2011
Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
Armin Gerger, Anthony El-Khoueiry, Wu Zhang, et al.
Oncotarget
|
July 25, 2016
Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012
Martin D Berger, Dongyun Yang, Yu Sunakawa, et al.
Plos One
|
July 18, 2013
Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab
Fotios Loupakis, Chiara Cremolini, Dongyun Yang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Journal of Geriatric Oncology
|
September 30, 2023
Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study
Gudrun Piringer, Josef Thaler, Sandro Anchisi, et al.
Anticancer Research
|
November 2, 2010
Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study)
Wu Zhang, Mizutomo Azuma, Georg Lurje, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2011
Common cancer stem cell gene variants predict colon cancer recurrence
Armin Gerger, Wu Zhang, Dongyun Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2012
Influence of sex on the survival of patients with esophageal cancer
Pierre Bohanes, Dongyun Yang, Ruchika S Chhibar, et al.
Cancers
|
July 27, 2022
Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study
Ralf-Dieter Hofheinz, Sandro Anchisi, Birgit Grünberger, et al.
BMC Cancer
|
February 20, 2021
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)
Karin Ribi, Beat Thürlimann, Corinne Schär, et al.
Journal of Bone Oncology
|
January 24, 2020
Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)
Michael Mark, Beat Thürlimann, Karin Ribi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 28, 2011
Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
Armin Gerger, Anthony El-Khoueiry, Wu Zhang, et al.
Oncotarget
|
July 25, 2016
Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012
Martin D Berger, Dongyun Yang, Yu Sunakawa, et al.
Plos One
|
July 18, 2013
Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab
Fotios Loupakis, Chiara Cremolini, Dongyun Yang, et al.
Page
of 3